Imatinib mesilate (Glivec ®, Novartis Pharmaceuticals) is a novel therapy for the treatment of chronic myeloid leukaemia (CML). We evaluated the cost-effectiveness of imatinib (600 mg daily ...

Recently, continuous regional arterial infusion (CRAI) with protease inhibitor of nafamostat mesilate and antibiotics has proven effective as an initial therapy in Japan. However, evidence ...

Efficacy and safety of use of somatostatin (SS) analogues in metastatic neuroendocrine tumours No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2008 ASCO ...

TrichostatinA to stimulate expression of Bridge-1 and Smad2, 3 and 4 of the ActivinA signaling cascade: Bridge-1-siRNA to enhance antiproliferative response to ActivinA in human breast cancer cells ...

This leaflet answers some common questions about DBL Desferrioxamine Mesylate for Injection BP (desferrioxamine mesilate). It does not contain all the available information. It does not take the ...

Details concerning the Dihydroergotamine Mesilate medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments ...

The European Medicines Agency has been formally notified by Novartis Europharm Ltd of its decision to withdraw its application for a centralised marketing authorisation for the medicine Ruvise ...

TOKYO, Sep 20, 2019 - (JCN Newswire) - Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. has announced the manufacturing and marketing approval in Japan for the indication of improvement of wearing ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to ...